These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16618734)

  • 1. High-throughput loss-of-heterozygosity study of chromosome 3p in lung cancer using single-nucleotide polymorphism markers.
    Tai AL; Mak W; Ng PK; Chua DT; Ng MY; Fu L; Chu KK; Fang Y; Qiang Song Y; Chen M; Zhang M; Sham PC; Guan XY
    Cancer Res; 2006 Apr; 66(8):4133-8. PubMed ID: 16618734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
    Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
    Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
    Grepmeier U; Dietmaier W; Merk J; Wild PJ; Obermann EC; Pfeifer M; Hofstaedter F; Hartmann A; Woenckhaus M
    Int J Oncol; 2005 Aug; 27(2):481-8. PubMed ID: 16010431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers.
    Zabarovsky ER; Lerman MI; Minna JD
    Oncogene; 2002 Oct; 21(45):6915-35. PubMed ID: 12362274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines.
    Jänne PA; Li C; Zhao X; Girard L; Chen TH; Minna J; Christiani DC; Johnson BE; Meyerson M
    Oncogene; 2004 Apr; 23(15):2716-26. PubMed ID: 15048096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of heterozygosity loss in chromosome 3p in non-microcytic bronchogenic carcinoma].
    Maestro ML; Izquierdo L; Sánchez-Pernaute A; Sanz Casla MT; González S; Torres A; del Barco V; Gómez A; Pérez Aguirre E; Balibrea JL
    Med Clin (Barc); 1999 Apr; 112(14):527-9. PubMed ID: 10363238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication.
    Mitsudomi T; Oyama T; Nishida K; Ogami A; Osaki T; Sugio K; Yasumoto K; Sugimachi K; Gazdar AF
    Clin Cancer Res; 1996 Jul; 2(7):1185-9. PubMed ID: 9816286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.
    Chmara M; Wozniak A; Ochman K; Kobierska G; Dziadziuszko R; Sosinska-Mielcarek K; Jassem E; Skokowski J; Jassem J; Limon J
    Anticancer Res; 2004; 24(6):4259-63. PubMed ID: 15736482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A candidate tumor suppressor gene, H37, from the human lung cancer tumor suppressor locus 3p21.3.
    Oh JJ; West AR; Fishbein MC; Slamon DJ
    Cancer Res; 2002 Jun; 62(11):3207-13. PubMed ID: 12036935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three distinct regions involved in 3p deletion in human lung cancer.
    Hibi K; Takahashi T; Yamakawa K; Ueda R; Sekido Y; Ariyoshi Y; Suyama M; Takagi H; Nakamura Y; Takahashi T
    Oncogene; 1992 Mar; 7(3):445-9. PubMed ID: 1347916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.
    Marsit CJ; Hasegawa M; Hirao T; Kim DH; Aldape K; Hinds PW; Wiencke JK; Nelson HH; Kelsey KT
    Cancer Res; 2004 Dec; 64(23):8702-7. PubMed ID: 15574780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
    Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
    Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays.
    Lindblad-Toh K; Tanenbaum DM; Daly MJ; Winchester E; Lui WO; Villapakkam A; Stanton SE; Larsson C; Hudson TJ; Johnson BE; Lander ES; Meyerson M
    Nat Biotechnol; 2000 Sep; 18(9):1001-5. PubMed ID: 10973224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.
    Ito M; Ito G; Kondo M; Uchiyama M; Fukui T; Mori S; Yoshioka H; Ueda Y; Shimokata K; Sekido Y
    Cancer Lett; 2005 Jul; 225(1):131-9. PubMed ID: 15922865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 3p and breast cancer.
    Yang Q; Yoshimura G; Mori I; Sakurai T; Kakudo K
    J Hum Genet; 2002; 47(9):453-9. PubMed ID: 12202982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.